Ardelyx Investigative Site 427

Meridian, Idaho 83642

We've found

1 trials

at this facility

An 8-Week Study to Evaluate Tenapanor in the Treatment of Hyperphosphatemia in End-Stage Renal Disease Patients on Hemodialysis (ESRD-HD)

Status: Enrolling, Phase II
Updated: 4/7/2016

from

Meridian, ID

Use our guide to learn which trials are right for you!